The recothrom market research report is one of a series of new reports that provides recothrom market statistics, including the recothrom industry global market size, regional shares, competitors with the recothrom market share, detailed recothrom market segments, market trends, and opportunities, and any further data you may need to thrive in the recothrom industry. This recothrom market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The growth in the forecast period can be attributed to rising incidences of trauma and accidental injuries, rising popularity of bioactive and biocompatible hemostats, growing adoption of thrombin in surgeries, rising awareness of surgical complications, and growing geriatric population. Major trends in the forecast period include advancements in wound care technology, technological advancements in hemostatic products, integration of thrombin in trauma and emergency care, integration of digital and smart technologies, and development of novel PCC formulations.
The growth of the recothrom market is expected to be driven by the increase in surgical procedures. A surgical procedure involves a medical operation performed by a surgeon to treat or diagnose a health condition, often including incisions, tissue removal, repair, or the use of instruments to address bodily issues. The rise in surgical procedures is being fueled by factors such as the increasing prevalence of chronic diseases, aging populations, and advancements in medical technology and minimally invasive techniques, which have improved patient outcomes and led to more surgeries being performed. Recothrom plays a crucial role in controlling bleeding during surgeries by promoting clot formation and enhancing the body's natural coagulation process for faster hemostasis. For example, in August 2024, the National Library of Medicine reported a 3.4% increase in the global volume of aesthetic procedures in 2023, totaling 34.9 million surgical and nonsurgical procedures, with over 15.8 million of these being surgical. This growth in surgical procedures is contributing to the expansion of the recothrom market.
Rising healthcare investments are also expected to boost the growth of the recothrom market. Healthcare investments involve the allocation of financial resources to the healthcare sector to support growth in areas such as medical research, healthcare services, pharmaceuticals, biotechnology, and healthcare technology. Factors driving healthcare investments include an aging population, advancements in medical technology, increasing healthcare costs, and the growing demand for innovative treatments and services. These investments support the development of products such as recothrom, a recombinant thrombin solution that enhances surgical outcomes and reduces complications. For instance, in May 2023, the Office for National Statistics reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, reflecting a 0.7% increase from 2021. This rise in healthcare investments is expected to further propel the growth of the recothrom market.
Advancements in flowable hemostats are also playing a significant role in the recothrom market. Flowable hemostats are medical devices or substances designed to control bleeding during surgery or trauma, especially in areas where traditional methods may not be as effective. In April 2023, Baxter International Inc. launched Floseal + Recothrom, a flowable hemostat aimed at improving hemostasis during surgeries. This innovative product combines a flowable gel with recombinant thrombin, utilizing recombinant DNA technology for the thrombin component, which eliminates the need for human blood donations, thus enhancing safety. Moreover, it offers a preparation time that is more than 1.5 times faster than traditional hemostatic agents, improving efficiency in surgical procedures.
The key company operating in the recothrom market is Baxter International Inc.
North America was the largest region in the recothrom market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in recothrom report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the recothrom market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Recothrom is a recombinant thrombin product used in surgical procedures to control bleeding by aiding in clot formation. As a topical hemostat, it helps stop bleeding in a specific area by promoting the formation of a clot. Recothrom is frequently utilized in surgeries where there is a risk of bleeding, including vascular, liver, and orthopedic surgeries.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for Recothrom are surgical procedures and trauma management. Surgical procedures involve medical interventions to treat or diagnose conditions through incisions or the use of specialized instruments. Available in both powder and solution forms, Recothrom is distributed through various channels such as direct sales, distributors, and online platforms, serving different end users, including hospitals, ambulatory surgical centers, and tactical combat casualty care units.
The recothrom market consists of sales of surgical hemostats, hemostatic sponges, fibrin sealants, single-dose vials, and lyophilized powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The growth in the forecast period can be attributed to rising incidences of trauma and accidental injuries, rising popularity of bioactive and biocompatible hemostats, growing adoption of thrombin in surgeries, rising awareness of surgical complications, and growing geriatric population. Major trends in the forecast period include advancements in wound care technology, technological advancements in hemostatic products, integration of thrombin in trauma and emergency care, integration of digital and smart technologies, and development of novel PCC formulations.
The growth of the recothrom market is expected to be driven by the increase in surgical procedures. A surgical procedure involves a medical operation performed by a surgeon to treat or diagnose a health condition, often including incisions, tissue removal, repair, or the use of instruments to address bodily issues. The rise in surgical procedures is being fueled by factors such as the increasing prevalence of chronic diseases, aging populations, and advancements in medical technology and minimally invasive techniques, which have improved patient outcomes and led to more surgeries being performed. Recothrom plays a crucial role in controlling bleeding during surgeries by promoting clot formation and enhancing the body's natural coagulation process for faster hemostasis. For example, in August 2024, the National Library of Medicine reported a 3.4% increase in the global volume of aesthetic procedures in 2023, totaling 34.9 million surgical and nonsurgical procedures, with over 15.8 million of these being surgical. This growth in surgical procedures is contributing to the expansion of the recothrom market.
Rising healthcare investments are also expected to boost the growth of the recothrom market. Healthcare investments involve the allocation of financial resources to the healthcare sector to support growth in areas such as medical research, healthcare services, pharmaceuticals, biotechnology, and healthcare technology. Factors driving healthcare investments include an aging population, advancements in medical technology, increasing healthcare costs, and the growing demand for innovative treatments and services. These investments support the development of products such as recothrom, a recombinant thrombin solution that enhances surgical outcomes and reduces complications. For instance, in May 2023, the Office for National Statistics reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion) in 2022, reflecting a 0.7% increase from 2021. This rise in healthcare investments is expected to further propel the growth of the recothrom market.
Advancements in flowable hemostats are also playing a significant role in the recothrom market. Flowable hemostats are medical devices or substances designed to control bleeding during surgery or trauma, especially in areas where traditional methods may not be as effective. In April 2023, Baxter International Inc. launched Floseal + Recothrom, a flowable hemostat aimed at improving hemostasis during surgeries. This innovative product combines a flowable gel with recombinant thrombin, utilizing recombinant DNA technology for the thrombin component, which eliminates the need for human blood donations, thus enhancing safety. Moreover, it offers a preparation time that is more than 1.5 times faster than traditional hemostatic agents, improving efficiency in surgical procedures.
The key company operating in the recothrom market is Baxter International Inc.
North America was the largest region in the recothrom market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in recothrom report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the recothrom market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Recothrom is a recombinant thrombin product used in surgical procedures to control bleeding by aiding in clot formation. As a topical hemostat, it helps stop bleeding in a specific area by promoting the formation of a clot. Recothrom is frequently utilized in surgeries where there is a risk of bleeding, including vascular, liver, and orthopedic surgeries.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary indications for Recothrom are surgical procedures and trauma management. Surgical procedures involve medical interventions to treat or diagnose conditions through incisions or the use of specialized instruments. Available in both powder and solution forms, Recothrom is distributed through various channels such as direct sales, distributors, and online platforms, serving different end users, including hospitals, ambulatory surgical centers, and tactical combat casualty care units.
The recothrom market consists of sales of surgical hemostats, hemostatic sponges, fibrin sealants, single-dose vials, and lyophilized powder. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Recothrom Market Characteristics4. Recothrom Market Trends And Strategies5. Recothrom Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market7. Global Recothrom Pricing Analysis & Forecasts30. Global Recothrom Market Competitive Benchmarking And Dashboard31. Key Mergers And Acquisitions In The Recothrom Market32. Recent Developments In The Recothrom Market
3. Recothrom Market Biologic Drug Characteristics
6. Global Recothrom Growth Analysis And Strategic Analysis Framework
8. Recothrom Market Segmentation
9. Global Recothrom Epidemiology Of Clinical Indications
10. Recothrom Market Regional And Country Analysis
11. Asia-Pacific Recothrom Market
12. China Recothrom Market
13. India Recothrom Market
14. Japan Recothrom Market
15. Australia Recothrom Market
16. South Korea Recothrom Market
17. Western Europe Recothrom Market
18. UK Recothrom Market
19. Germany Recothrom Market
20. France Recothrom Market
21. Eastern Europe Recothrom Market
22. North America Recothrom Market
23. USA Recothrom Market
24. Canada Recothrom Market
25. South America Recothrom Market
26. Middle East Recothrom Market
27. Africa Recothrom Market
28. Recothrom Market Competitive Landscape And Company Profiles
29. Global Recothrom Market Pipeline Analysis
33. Recothrom Market High Potential Countries, Segments and Strategies
34. Appendix
Executive Summary
Recothrom Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on recothrom market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for recothrom ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The recothrom market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Indication: Surgical Procedures; Trauma Management2) By Formulation: Powder Form; Solution Form
3) By Distribution Channel: Direct Sales; Distributors; Online Sales
4) By End User: Hospitals; Ambulatory Surgical Centers; Tactical Combat Casualty Care
Key Companies Profiled: Baxter International Inc.
Countries: Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Baxter International Inc.
